Research Article
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
Table 4
Predictive factors associated with severe COVID-19 outcome.
| | Factor variable | Univariate OR (95% CI) | valve | Multivariate OR (95% CI) | valve |
| | Age >55 years | 11.09 (1.81–68.09) | 0.02 | 10.86 (1.64–72.07) | 0.013 | | Active IBD clinical activity | 3.80 (0.69–20.78) | 0.10 | 3.19 (0.41–25.0) | 0.269 | | Systemic corticosteroid | 4.64 (0.72–30.06) | 0.08 | 2.08 (0.21–20.78) | 0.531 | | Comorbidity (≥1 major comorbidity) | 4.86 (0.83–28.60) | 0.08 | NA | NA |
|
|
OR: odds ratio, CI: confidence interval, NA: not available.
|
